Poirier, A.; Gagné, A.; Laflamme, P.; Marcoux, M.; Orain, M.; Plante, S.; Joubert, D.; Joubert, P.; Laplante, M.
ZNF768 Expression Associates with High Proliferative Clinicopathological Features in Lung Adenocarcinoma. Cancers 2021, 13, 4136.
https://doi.org/10.3390/cancers13164136
AMA Style
Poirier A, Gagné A, Laflamme P, Marcoux M, Orain M, Plante S, Joubert D, Joubert P, Laplante M.
ZNF768 Expression Associates with High Proliferative Clinicopathological Features in Lung Adenocarcinoma. Cancers. 2021; 13(16):4136.
https://doi.org/10.3390/cancers13164136
Chicago/Turabian Style
Poirier, Audrey, Andréanne Gagné, Philippe Laflamme, Meagan Marcoux, Michèle Orain, Sophie Plante, David Joubert, Philippe Joubert, and Mathieu Laplante.
2021. "ZNF768 Expression Associates with High Proliferative Clinicopathological Features in Lung Adenocarcinoma" Cancers 13, no. 16: 4136.
https://doi.org/10.3390/cancers13164136
APA Style
Poirier, A., Gagné, A., Laflamme, P., Marcoux, M., Orain, M., Plante, S., Joubert, D., Joubert, P., & Laplante, M.
(2021). ZNF768 Expression Associates with High Proliferative Clinicopathological Features in Lung Adenocarcinoma. Cancers, 13(16), 4136.
https://doi.org/10.3390/cancers13164136